Publication
A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa
| Summary: | This thesis examines the optimal market entry strategy for Sanofi's expansion into the African insulin market. Grounded in a theoretical framework that identifies factors influencing the choice of market entry mode, the study evaluates internal capabilities and external conditions. Key findings suggest significant opportunities for Sanofi due to a largely untapped market, strong internal capabilities, and a growing demand for insulin. Recommendations include pursuing a greenfield venture in Kenya to establish production facilities in Africa. With the support of the local government and international institutions, Sanofi can minimize operational risks, reduce capital expenditures, and, ultimately, improve insulin accessibility across Africa. |
|---|---|
| Main Authors: | Klaus, David Christopher |
| Subject: | Market entry mode Insulin access Africa Healthcare CEMS MIM |
| Year: | 2024 |
| Country: | Portugal |
| Document type: | master thesis |
| Access type: | embargoed access |
| Associated institution: | Universidade Nova de Lisboa |
| Language: | English |
| Origin: | Repositório Institucional da UNL |
| _version_ | 1868982888907669504 |
|---|---|
| author | Klaus, David Christopher |
| author_facet | Klaus, David Christopher |
| author_role | author |
| contributor_name_str_mv | Decreton, Benoit RUN |
| country_str | PT |
| creators_json_txt | [{\"Person.name\":\"Klaus, David Christopher\"}] |
| datacite.contributors.contributor.contributorName.fl_str_mv | Decreton, Benoit RUN |
| datacite.creators.creator.creatorName.fl_str_mv | Klaus, David Christopher |
| datacite.date.Accepted.fl_str_mv | 2024-09-30T00:00:00Z |
| datacite.date.available.fl_str_mv | 2029-06-19T00:00:00Z |
| datacite.date.embargoed.fl_str_mv | 2029-06-19T00:00:00Z |
| datacite.rights.fl_str_mv | http://purl.org/coar/access_right/c_f1cf |
| datacite.subjects.subject.fl_str_mv | Market entry mode Insulin access Africa Healthcare CEMS MIM |
| datacite.titles.title.fl_str_mv | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa |
| dc.contributor.none.fl_str_mv | Decreton, Benoit RUN |
| dc.creator.none.fl_str_mv | Klaus, David Christopher |
| dc.date.Accepted.fl_str_mv | 2024-09-30T00:00:00Z |
| dc.date.available.fl_str_mv | 2029-06-19T00:00:00Z |
| dc.date.embargoed.fl_str_mv | 2029-06-19T00:00:00Z |
| dc.format.none.fl_str_mv | application/pdf |
| dc.identifier.none.fl_str_mv | http://hdl.handle.net/10362/181501 |
| dc.language.none.fl_str_mv | eng |
| dc.rights.none.fl_str_mv | http://purl.org/coar/access_right/c_f1cf |
| dc.subject.none.fl_str_mv | Market entry mode Insulin access Africa Healthcare CEMS MIM |
| dc.title.fl_str_mv | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa |
| dc.type.none.fl_str_mv | http://purl.org/coar/resource_type/c_bdcc |
| description | This thesis examines the optimal market entry strategy for Sanofi's expansion into the African insulin market. Grounded in a theoretical framework that identifies factors influencing the choice of market entry mode, the study evaluates internal capabilities and external conditions. Key findings suggest significant opportunities for Sanofi due to a largely untapped market, strong internal capabilities, and a growing demand for insulin. Recommendations include pursuing a greenfield venture in Kenya to establish production facilities in Africa. With the support of the local government and international institutions, Sanofi can minimize operational risks, reduce capital expenditures, and, ultimately, improve insulin accessibility across Africa. |
| dirty | 0 |
| eu_rights_str_mv | embargoedAccess |
| format | masterThesis |
| fulltext.url.fl_str_mv | https://run.unl.pt/bitstreams/842709b8-eb0f-41fc-b24b-805cb31c23ec/download |
| id | run_bdf39dbfa1ae80cb4c7f79a05798e652 |
| identifier.url.fl_str_mv | http://hdl.handle.net/10362/181501 |
| inst_facet_str | urn:organizationAcronym:unl{{{_:::_}}}Universidade Nova de Lisboa |
| instacron_str | unl |
| institution | Universidade Nova de Lisboa |
| instname_str | Universidade Nova de Lisboa |
| language | eng |
| network_acronym_str | run |
| network_name_str | Repositório Institucional da UNL |
| oai_identifier_str | oai:run.unl.pt:10362/181501 |
| organization_str_mv | urn:organizationAcronym:unl |
| person_str_mv | Klaus, David Christopher |
| publishDate | 2024 |
| repo_facet_str | urn:repositoryAcronym:run{{{_:::_}}}Repositório Institucional da UNL |
| reponame_str | Repositório Institucional da UNL |
| repository_id_str | urn:repositoryAcronym:run |
| service_str_mv | urn:repositoryAcronym:run |
| spelling | engpt_PTThis thesis examines the optimal market entry strategy for Sanofi's expansion into the African insulin market. Grounded in a theoretical framework that identifies factors influencing the choice of market entry mode, the study evaluates internal capabilities and external conditions. Key findings suggest significant opportunities for Sanofi due to a largely untapped market, strong internal capabilities, and a growing demand for insulin. Recommendations include pursuing a greenfield venture in Kenya to establish production facilities in Africa. With the support of the local government and international institutions, Sanofi can minimize operational risks, reduce capital expenditures, and, ultimately, improve insulin accessibility across Africa.application/pdfpt_PTA strategic analysis of entry mode choices for Sanofi in the insulin market of AfricaKlaus, David ChristopherDecreton, BenoitHostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptURNurn:tid:2038666142024-09-302024-06-192029-06-19T00:00:00Z2024-09-30T00:00:00ZHandlehttp://hdl.handle.net/10362/181501http://purl.org/coar/access_right/c_f1cfembargoed accessMarket entry modeInsulin accessAfricaHealthcareCEMS MIM3712477 bytesliteraturehttp://purl.org/coar/resource_type/c_bdccmaster thesishttp://purl.org/coar/access_right/c_f1cfapplication/pdffulltexthttps://run.unl.pt/bitstreams/842709b8-eb0f-41fc-b24b-805cb31c23ec/download |
| spellingShingle | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa Klaus, David Christopher Market entry mode Insulin access Africa Healthcare CEMS MIM |
| status | SINGLETON |
| subject.fl_str_mv | Market entry mode Insulin access Africa Healthcare CEMS MIM |
| title | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa |
| title_full | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa |
| title_fullStr | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa |
| title_full_unstemmed | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa |
| title_short | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa |
| title_sort | A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa |
| topic | Market entry mode Insulin access Africa Healthcare CEMS MIM |
| topic_facet | Market entry mode Insulin access Africa Healthcare CEMS MIM |
| url | http://hdl.handle.net/10362/181501 |
| visible | 1 |